Top Page
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
(Sydney:EBR)
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR) vs. iShares MSCI Australia ETF (EWA)
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Business Overview & Revenue Model
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 681.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 308.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -38.60M | -37.73M | -24.66M | -23.62M | ― | ― |
| Net Income | -44.81M | -20.17M | -35.04M | -33.09M | ― | ― |
Balance Sheet | ||||||
| Total Assets | 104.99M | 73.56M | 78.90M | 71.68M | 85.42M | 8.40M |
| Cash, Cash Equivalents and Short-Term Investments | 68.36M | 60.66M | 72.32M | 63.53M | 78.24M | 5.88M |
| Total Debt | 56.80M | 41.40M | 41.59M | 21.59M | 4.81M | 33.23M |
| Total Liabilities | 66.34M | 49.20M | 47.84M | 27.73M | 9.53M | 46.05M |
| Stockholders Equity | 38.65M | 24.36M | 31.06M | 43.95M | 75.90M | -37.65M |
Cash Flow | ||||||
| Free Cash Flow | -51.46M | -41.50M | -33.05M | -31.09M | ― | ― |
| Operating Cash Flow | -49.17M | -41.23M | -32.70M | -30.36M | ― | ― |
| Investing Cash Flow | -21.45M | 1.11M | -8.64M | -49.35M | -906.81K | ― |
| Financing Cash Flow | 49.45M | 32.48M | 40.47M | 17.01M | 95.76M | 16.41K |
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Technical Analysis
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$25.13M | -2.62 | -103.74% | ― | 14.84% | 39.64% | |
48 Neutral | AU$29.98M | -4.68 | -58.27% | ― | -7.20% | 28.70% | |
44 Neutral | AU$418.43M | -5.53 | -134.69% | ― | ― | ― | |
44 Neutral | AU$172.40M | -16.13 | -70.55% | ― | ― | -257.32% | |
41 Neutral | AU$65.87M | -3.72 | -128.19% | ― | -14.25% | -22.83% | |
37 Underperform | AU$21.46M | -0.64 | -1476.79% | ― | -2.82% | 32.47% |
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Corporate Events
EBR Systems, Inc. has announced the cessation of 170,480 securities due to the lapse of conditional rights, as the conditions for these securities were not met or became incapable of being satisfied. This announcement, made on December 15, 2025, reflects a change in the company’s issued capital and could impact stakeholders’ perception of the company’s financial strategies and market positioning.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. announced the first patient enrolment and implant in the Totally Leadless CRT (TLC-AU) study, marking a significant milestone in the development of its WiSE System as a first-line therapy for heart failure patients. This study, conducted in Australia, aims to evaluate the feasibility of using the WiSE System with a leadless pacemaker to provide a totally leadless CRT solution, potentially expanding EBR’s addressable market and reinforcing its leadership in heart-failure treatment.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems Inc. announced the issuance of 207,000 unquoted equity securities as part of an employee incentive scheme. This move is likely aimed at retaining and motivating employees by providing them with a stake in the company’s future success, potentially impacting the company’s operational dynamics and aligning employee interests with those of the shareholders.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced the expansion of its intellectual property portfolio with the granting of four new patents, three from the US Patent and Trademark Office and one from the Japan Patent Office. This development enhances the protection of its WiSE technology, the world’s only wireless cardiac pacing device for heart failure, and extends the patent runway for its innovations. However, the company has received a preliminary disallowance notice from the USPTO regarding a patent term extension application, which it is currently addressing. The continued growth of EBR’s patent portfolio underscores its commitment to research and development, potentially strengthening its market position and creating barriers for competitors.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company is set to quote 117,303 securities under the ASX code EBR, with the issue date being December 1, 2025. This move is part of the company’s strategy to enhance its market presence and potentially attract more investors. The announcement signifies a step forward in EBR Systems’ efforts to expand its financial operations and strengthen its position in the market.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has released a presentation providing general information about its activities and financial status. The document emphasizes the company’s compliance with regulatory requirements and highlights that its CHESS Depositary Interests are traded on the ASX. The release serves as an informational update rather than a financial advisory, indicating that stakeholders should seek independent advice for investment decisions.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. announced its participation in the Bell Potter Healthcare Conference 2025, where management will present their pioneering wireless cardiac pacing technology. This virtual event provides a platform for EBR Systems to showcase its WiSE technology, which could significantly impact the cardiac pacing industry by offering a more anatomically correct and less invasive solution for heart failure patients. The conference presentation is an opportunity for EBR Systems to strengthen its industry positioning and engage with stakeholders about its innovative approach to cardiac rhythm management.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.86 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. announced the cessation of certain securities, specifically 309,278 warrants and 69,105 options, due to their expiration without exercise or conversion as of November 3, 2025. This development may impact the company’s capital structure and could influence investor perceptions and market positioning.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. announced significant progress in Q3 2025, securing CMS approval for both NTAP and TPT reimbursement for its WiSE CRT System, effective October 2025. This approval establishes a comprehensive Medicare reimbursement pathway, enhancing the system’s adoption in both inpatient and outpatient settings. The company reported a 201% increase in revenue from Q2 to Q3 2025, driven by a tripling of case volumes and successful pilot launches. EBR also advanced its Limited Market Release preparations, signing additional purchasing agreements and training physicians, which aligns with the commencement of U.S. Medicare reimbursement programs. These developments are expected to accelerate the adoption and operational processes of the WiSE CRT System, positioning EBR for further growth.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced the issuance of 357,000 unquoted equity securities under an employee incentive scheme, which are not intended to be listed on the ASX. This move is part of the company’s strategy to motivate and retain its workforce, potentially impacting its operational efficiency and market competitiveness positively.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced the application for quotation of new securities on the Australian Securities Exchange (ASX). The company plans to quote 30,208 new securities under the code EBR CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB, with an issue date of November 3, 2025. This move could potentially enhance the company’s market presence and provide additional liquidity options for stakeholders.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced the enrollment of the first two patients in its WiSE-UP post-approval study, which aims to collect real-world evidence on the effectiveness of the WiSE left ventricular endocardial pacing system for cardiac resynchronization therapy. This significant milestone involves tracking over 300 patients across 50 US centers over five years, providing valuable insights into both short- and long-term outcomes. The study is expected to enhance the understanding of CRT applications and improve standards of care for heart failure patients, thereby strengthening EBR Systems’ position in the cardiac rhythm management industry.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York, highlighting its innovative WiSE technology. This participation underscores EBR’s commitment to advancing cardiac pacing solutions and may enhance its visibility and positioning in the medical technology industry.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced its participation in several upcoming investor conferences, where key executives will present and engage with investors. These engagements are expected to enhance EBR’s visibility in the market and provide insights into the company’s strategic direction and technological advancements. The participation in these conferences could potentially strengthen EBR’s industry positioning and foster relationships with stakeholders, as the company continues to innovate in the field of cardiac pacing.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. announced the cessation of 56,091 securities due to the lapse of conditional rights, as the conditions for these securities have not been met or have become incapable of being satisfied. This announcement may impact the company’s capital management strategy and could influence stakeholder perceptions regarding the company’s operational efficiency and future financial planning.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The announcement details the issuance of 141,353 securities, which will be quoted under the ASX security code ‘EBR CDI 1:1 US PERSON PROHIBITED’ as of October 1, 2025. This move is part of the company’s strategic efforts to enhance its market presence and potentially attract more investors, reflecting its ongoing commitment to expanding its financial activities.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
EBR Systems, Inc. has announced an investor roadshow in Australia from November 4 to November 6, 2025, offering securityholders a chance to engage with the company’s Chief Corporate Development Officer, Andrew Shute, and an Australian-based implanter. The roadshow will provide updates on recent milestones and insights into the commercialization pathway of EBR’s innovative wireless cardiac pacing technology. This initiative reflects EBR’s commitment to enhancing stakeholder engagement and expanding its market presence, potentially impacting its industry positioning by showcasing its cutting-edge technology and future applications.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.